United States · FDA National Drug Code directory
Cefaclor
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 81948-6250_a6a7fcf7-b9dc-4dac-b127-418588586a8a
- Product NDC
- 81948-6250
- Form
- SUSPENSION
- Composition / generic term
- cefaclor
- Labeler
- Azorian Pharma, LLC
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20221101
- Source listing expiry
- 20261231
Source-listed ingredients
- CEFACLOR — 250 mg/5mL
These values do not establish equivalence or a dose recommendation.
Packages
- 150 mL in 1 BOTTLE (81948-6250-1) · 81948-6250-1
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →